http://www.prnewswire.co.uk/rss/health/infection-control-news.rss Press Releases from PR Newswire about Infection Control en-us Fri, 24 May 2013 18:44:11 EDT Mon, 20 May 2013 03:00:00 EDT http://www.prnewswire.co.uk/news-releases/oxitec-report-96-suppression-of-the-dengue-mosquito-in-brazilian-trials-208099571.html http://www.prnewswire.co.uk/news-releases/oxitec-report-96-suppression-of-the-dengue-mosquito-in-brazilian-trials-208099571.html Mon, 20 May 2013 03:00:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.co.uk/news-releases/the-world-small-animal-veterinary-association-recommends-canine-vaccicheck-207694701.html http://www.prnewswire.co.uk/news-releases/the-world-small-animal-veterinary-association-recommends-canine-vaccicheck-207694701.html Thu, 16 May 2013 09:00:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.co.uk/news-releases/combination-drugs-are-the-future-of-the-european-hepatitis-b-and-c-therapeutics-markets-says-frost--sullivan-205531971.html http://www.prnewswire.co.uk/news-releases/combination-drugs-are-the-future-of-the-european-hepatitis-b-and-c-therapeutics-markets-says-frost--sullivan-205531971.html Wed, 01 May 2013 04:00:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.co.uk/news-releases/mylan-delivers-much-anticipated-one-pill-once-a-day-triple-fixed-dose-antiretroviral-combination-to-the-south-african-national-department-of-health-203242531.html http://www.prnewswire.co.uk/news-releases/mylan-delivers-much-anticipated-one-pill-once-a-day-triple-fixed-dose-antiretroviral-combination-to-the-south-african-national-department-of-health-203242531.html Tue, 16 Apr 2013 14:11:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.co.uk/news-releases/intelligentmdx-announces-ce-marking-of-a-test-for-detection-and-differentiation-of-influenza-a-influenza-b-and-respiratory-syncytial-virus-on-the-abbott-m2000-realtime-system-202998511.html http://www.prnewswire.co.uk/news-releases/intelligentmdx-announces-ce-marking-of-a-test-for-detection-and-differentiation-of-influenza-a-influenza-b-and-respiratory-syncytial-virus-on-the-abbott-m2000-realtime-system-202998511.html Mon, 15 Apr 2013 08:28:00 EDT CAMBRIDGE, Massachusetts, April 15, 2013 /PRNewswire/ -- IntelligentMDx (IMDx) announced today that it has obtained CE-marking for a multiplexed, real-time PCR test for detection and differentiation of Influenza A, Influenza B, and Respiratory Syncytial Virus. This test is the...

]]>

]]> PRNewswire en-US PR Newswire Association LLC. http://www.prnewswire.co.uk/news-releases/intelligentmdx-anuncia-la-marca-ce-para-un-test-de-deteccion-de-la-gripe-a-b-y-virus-respiratorio-sincitial-202998471.html http://www.prnewswire.co.uk/news-releases/intelligentmdx-anuncia-la-marca-ce-para-un-test-de-deteccion-de-la-gripe-a-b-y-virus-respiratorio-sincitial-202998471.html Mon, 15 Apr 2013 08:28:00 EDT - IntelligentMDx anuncia la Marca CE para un test de detección y diferenciación de la gripe A, gripe B y virus respiratorio sincitial con el sistema en tiempo real Abbott m2000 CAMBRIDGE, Massachusetts, 15 de abril de 2013 /PRNewswire/ -- IntelligentMDx (IMDx) anunció...

]]>

]]> PRNewswire es PR Newswire Association LLC. http://www.prnewswire.co.uk/news-releases/intelligentmdx-gibt-ce-kennzeichnung-eines-tests-zum-nachweis-und-zur-differenzierung-von-influenza-a-influenza-b-und-respiratorischem-synzytialvirus-in-echtzeit-system-abbott-m2000-bekannt-202998481.html http://www.prnewswire.co.uk/news-releases/intelligentmdx-gibt-ce-kennzeichnung-eines-tests-zum-nachweis-und-zur-differenzierung-von-influenza-a-influenza-b-und-respiratorischem-synzytialvirus-in-echtzeit-system-abbott-m2000-bekannt-202998481.html Mon, 15 Apr 2013 08:28:00 EDT CAMBRIDGE, Massachusetts, 15. April 2013 /PRNewswire/ -- IntelligentMDx (IMDx) gab heute bekannt, dass das Unternehmen die CE-Kennzeichnung für einen gemultiplexten Echtzeit-PCR-Test zum Nachweis und zur Differenzierung von Influenza A, Influenza B und des respiratorischen...

]]>

]]> PRNewswire de PR Newswire Association LLC. http://www.prnewswire.co.uk/news-releases/intelligentmdx-annonce-lobtention-de-lhomologation-ce-pour-son-test-de-detection-et-de-differenciation-de-la-grippe-a-de-la-grippe-b-et-du-virus-respiratoire-syncytial-employe-dans-le-cadre-du-systeme-m2000-realtime-dabbott-202998461.html http://www.prnewswire.co.uk/news-releases/intelligentmdx-annonce-lobtention-de-lhomologation-ce-pour-son-test-de-detection-et-de-differenciation-de-la-grippe-a-de-la-grippe-b-et-du-virus-respiratoire-syncytial-employe-dans-le-cadre-du-systeme-m2000-realtime-dabbott-202998461.html Mon, 15 Apr 2013 08:28:00 EDT CAMBRIDGE, Massachusetts, 15 avril 2013 /PRNewswire/ -- IntelligentMDx (IMDx) a annoncé aujourd'hui avoir obtenu le marquage CE pour un test PCR multiplexe en temps réel de détection et de différenciation de la grippe A, de la grippe B et du...

]]>

]]> PRNewswire fr PR Newswire Association LLC. http://www.prnewswire.co.uk/news-releases/die-vogelgrippe-a-h7n9-droht---genscript-unterstutzt-forscher-im-bevorstehenden-kampf-mit-genetischem-eilservice-202583481.html http://www.prnewswire.co.uk/news-releases/die-vogelgrippe-a-h7n9-droht---genscript-unterstutzt-forscher-im-bevorstehenden-kampf-mit-genetischem-eilservice-202583481.html Thu, 11 Apr 2013 16:19:00 EDT de PR Newswire Association LLC. http://www.prnewswire.co.uk/news-releases/alors-que-la-menace-du-virus-de-la-grippe-aviaire-a-h7n9-plane-genscript-propose-le-service-rush-gene-synthesis-pour-aider-les-chercheurs-face-a-une-bataille-imminente-202581801.html http://www.prnewswire.co.uk/news-releases/alors-que-la-menace-du-virus-de-la-grippe-aviaire-a-h7n9-plane-genscript-propose-le-service-rush-gene-synthesis-pour-aider-les-chercheurs-face-a-une-bataille-imminente-202581801.html Thu, 11 Apr 2013 16:11:00 EDT fr PR Newswire Association LLC. http://www.prnewswire.co.uk/news-releases/ante-la-amenaza-de-la-gripe-aviar-a-h7n9-genscript-apoya-a-los-investigadores-202548541.html http://www.prnewswire.co.uk/news-releases/ante-la-amenaza-de-la-gripe-aviar-a-h7n9-genscript-apoya-a-los-investigadores-202548541.html Thu, 11 Apr 2013 13:03:00 EDT es PR Newswire Association LLC. http://www.prnewswire.co.uk/news-releases/avian-influenza-a-h7n9-threatens-genscript-supports-researchers-in-impending-battle-with-rush-gene-service-202504101.html http://www.prnewswire.co.uk/news-releases/avian-influenza-a-h7n9-threatens-genscript-supports-researchers-in-impending-battle-with-rush-gene-service-202504101.html Thu, 11 Apr 2013 09:00:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.co.uk/news-releases/arcdia-international-ltd-the-multianalyte-point-of-care-company-for-infectious-diseases-strengthens-management-202475621.html http://www.prnewswire.co.uk/news-releases/arcdia-international-ltd-the-multianalyte-point-of-care-company-for-infectious-diseases-strengthens-management-202475621.html Thu, 11 Apr 2013 05:06:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.co.uk/news-releases/equatorial-guineas-eg-ministry-of-health-convenes-in-washington-dc-with-gb-group-global-and-tni-biotech-otcbbtnib-to-launch-major-innovative-health-solutions-and-improve-pharmaceutical-quality-for-its-citizens-201904071.html http://www.prnewswire.co.uk/news-releases/equatorial-guineas-eg-ministry-of-health-convenes-in-washington-dc-with-gb-group-global-and-tni-biotech-otcbbtnib-to-launch-major-innovative-health-solutions-and-improve-pharmaceutical-quality-for-its-citizens-201904071.html Mon, 08 Apr 2013 06:30:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.co.uk/news-releases/hiv-aids-testing-markets-a-comprehensive-market-guide-featuring-over-30-leading-players-201043191.html http://www.prnewswire.co.uk/news-releases/hiv-aids-testing-markets-a-comprehensive-market-guide-featuring-over-30-leading-players-201043191.html Tue, 02 Apr 2013 09:30:00 EDT DUBLIN, April 2, 2013 /PRNewswire/ -- Research and Markets has announced the addition of the "HIV-AIDS Testing Markets" report to their offering. There are an estimated 33.3 million people living with HIV (the virus which causes AIDS) worldwide and approximately 2.6 million people are...

]]>

]]> PRNewswire en-US PR Newswire Association LLC. http://www.prnewswire.co.uk/news-releases/molecular-diagnostics-in-infectious-disease-testing-201040681.html http://www.prnewswire.co.uk/news-releases/molecular-diagnostics-in-infectious-disease-testing-201040681.html Tue, 02 Apr 2013 09:15:00 EDT DUBLIN, April 2, 2013 /PRNewswire/ -- Research and Markets has announced the addition of the "Molecular Diagnostics in Infectious Disease Testing" report to their offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) This report describes the...

]]>

]]> PRNewswire en-US PR Newswire Association LLC. http://www.prnewswire.co.uk/news-releases/forskning-udgivet-i-new-england-journal-of-medicine-paviser-markant-og-langvarig-antiviral-aktivitet-mod-hcv-for-santaris-pharma-as-miravirsen-det-forste-microrna-rettede-laegemiddel-til-at-indga-i-kliniske-forsog-200401471.html http://www.prnewswire.co.uk/news-releases/forskning-udgivet-i-new-england-journal-of-medicine-paviser-markant-og-langvarig-antiviral-aktivitet-mod-hcv-for-santaris-pharma-as-miravirsen-det-forste-microrna-rettede-laegemiddel-til-at-indga-i-kliniske-forsog-200401471.html Thu, 28 Mar 2013 06:34:00 EDT -- Endelig fase 2a-resultater viser dosisafhængig, langtidsvirkende antiviral aktivitet hos patienter med hepatitis C -- HØRSHOLM, Danmark, og SAN DIEGO, den 28. marts 2013 /PRNewswire/ -- Santaris Pharma A/S, en klinisk-faset, biofarmaceutisk virksomhed, der fokuserer...

]]>

]]> PRNewswire da PR Newswire Association LLC. http://www.prnewswire.co.uk/news-releases/research-published-in-the-new-england-journal-of-medicine-demonstrates-marked-and-long-lasting-antiviral-activity-against-hcv-for-santaris-pharma-as-miravirsen-the-first-microrna-targeted-drug-to-enter-clinical-trials-200308351.html http://www.prnewswire.co.uk/news-releases/research-published-in-the-new-england-journal-of-medicine-demonstrates-marked-and-long-lasting-antiviral-activity-against-hcv-for-santaris-pharma-as-miravirsen-the-first-microrna-targeted-drug-to-enter-clinical-trials-200308351.html Wed, 27 Mar 2013 17:00:00 EDT -- Final Phase 2a results show dose-dependent, prolonged antiviral activity in Hepatitis C patients -- HOERSHOLM, Denmark and SAN DIEGO, March 27, 2013 /PRNewswire/ -- Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of...

]]>

]]> PRNewswire en-US PR Newswire Association LLC. http://www.prnewswire.co.uk/news-releases/nutra-pharma-patent-and-trademarks-published-in-india-199847501.html http://www.prnewswire.co.uk/news-releases/nutra-pharma-patent-and-trademarks-published-in-india-199847501.html Mon, 25 Mar 2013 09:00:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.co.uk/news-releases/therapeutic-proteins-to-2016-drugs-devices-diseases-markets-and-forecasts-199533701.html http://www.prnewswire.co.uk/news-releases/therapeutic-proteins-to-2016-drugs-devices-diseases-markets-and-forecasts-199533701.html Fri, 22 Mar 2013 10:00:00 EDT DUBLIN, March 22, 2013 /PRNewswire/ -- Research and Markets has announced the addition of the "Therapeutic Proteins to 2016. Drugs, Devices, Diseases, Markets and Forecasts" report to their offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769...

]]>

]]> PRNewswire en-US PR Newswire Association LLC.